[6-K] Gelteq Limited Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Golden Matrix Group, Inc. (GMGI) Form 4 filing: Director Thomas E. McChesney reported two open-market stock sales. On 23 June 2025 he sold 5,000 common shares at $1.65; on 24 June 2025 he sold another 5,000 shares at $1.82. Following the transactions, McChesney directly owns 284,710 GMGI shares, remaining a board member and >10% owner status is not indicated. The filing discloses no derivative activity, contracts, or 10b5-1 plans. Investors may view the combined 10,000-share sale as modest (≈3% of his reported stake) but worth monitoring for future insider-trading trends.

Positive

• None.

Negative

• Director insider selling: Thomas McChesney sold a total of 10,000 GMGI shares on 23-24 Jun 2025 at $1.65-$1.82, reducing his stake to 284,710 shares.

Insights

Securities Analyst

TL;DR: Director trimmed 3% of holdings; modest insider sale, limited market impact.

The Form 4 shows Thomas McChesney executed two small sell orders totaling 10,000 shares at prices ranging from $1.65-$1.82, leaving him with 284,710 shares. The disposal represents roughly 3-4 % of his reported ownership, signalling portfolio rebalancing rather than a strategic exit. No accompanying 10b5-1 annotation suggests discretionary timing, yet the size is insufficient to materially alter the company’s insider-ownership profile. Overall market impact is likely neutral, though continued selling could indicate waning insider confidence.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number: 001-42373

Gelteq Limited

(Registrant’s Name)

Level 4
100 Albert Road
South Melbourne VIC, 3025
Australia

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒        Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT 

Gelteq Limited (the “Company”) is filing its unaudited financial results for the six months ended December 31, 2024 and to discuss its recent corporate developments. Attached as exhibits to this Report on Form 6-K are:

● the management’s discussion and analysis of financial condition and results of operations as Exhibit 99.1;

● the unaudited condensed consolidated financial statements and related notes as Exhibit 99.2; and

● interactive data file disclosure as Exhibit 101 in accordance with Rule 405 of Regulation S-T.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report on Form 6-K and the exhibits hereto contain “forward-looking statements” for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that represent the Company’s beliefs, projections and predictions about future events. All statements other than statements of historical fact are “forward-looking statements,” including any projections of earnings, revenue or other financial items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other developments, any statements regarding future economic conditions or performance, any statements of management’s beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words such as “may”, “will”, “should”, “could”, “would”, “predicts”, “potential”, “continue”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates” and similar expressions, as well as statements in the future tense, identify forward-looking statements.

These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause the Company’s actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual results may differ materially from expected results described in the Company’s forward-looking statements, including with respect to correct measurement and identification of factors affecting the Company’s business or the extent of their likely impact, and the accuracy and completeness of the publicly available information with respect to the factors upon which the Company’s business strategy is based or the success of the Company’s business.

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of whether, or the times by which, the Company’s performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management’s belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, those factors discussed more fully under the caption “Risk Factors” as well as other risks and factors identified from time to time in the Company’s SEC filings.

1

Financial Statements and Exhibits.

The following exhibits are being filed herewith:

Exhibit Number		Description
99.1		Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended December 31, 2024 and 2023
99.2		Condensed Consolidated Financial Statements for the Six Months Ended December 31, 2024 and 2023
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Gelteq Limited
	By:	/s/ Nathan Givoni
	Name:	Nathan Givoni
	Title:	Chief Executive Officer

Date: June 30, 2025

3

FAQ

How many GMGI shares did Director Thomas McChesney sell?

He sold 10,000 common shares across two transactions.

At what prices were the GMGI shares sold according to the Form 4?

The shares were sold at $1.65 on 23 Jun 2025 and $1.82 on 24 Jun 2025.

How many GMGI shares does McChesney own after these transactions?

He directly owns 284,710 shares following the reported sales.

What is Thomas McChesney’s relationship to Golden Matrix Group?

He is listed as a Director of the company.

Were any derivative securities involved in this Form 4 filing?

No. The filing shows no derivative securities acquired or disposed.